PriceTargets.com logo

NYSE:DOC - Physicians Realty Trust Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $18.70
  • Forecasted Upside: 4.29 %
  • Number of Analysts: 11
  • Breakdown:
  • 1 Sell Ratings
  • 8 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$17.93 As of 08/10/2022 11:50 AM ET
▲ +0.12 (0.67%)

This chart shows the closing price for DOC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Physicians Realty Trust Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DOC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DOC

Analyst Price Target is $18.70
▲ +4.29% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for Physicians Realty Trust in the last 3 months. The average price target is $18.70, with a high forecast of $20.00 and a low forecast of $16.00. The average price target represents a 4.29% upside from the last price of $17.93.

This chart shows the closing price for DOC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 11 polled investment analysts is to hold stock in Physicians Realty Trust. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 10 hold ratings
  • 0 sell ratings
Ratings as of
2/15/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
5/16/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
8/14/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
11/12/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
2/10/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
5/11/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
7/10/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 1 sell ratings
Ratings as of
8/9/2022

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/5/2022Colliers SecuritiesDowngradeBuy ➝ Neutral$19.00Low
7/15/2022Morgan StanleyLower Price TargetEqual Weight$17.50 ➝ $16.00Low
7/11/2022Truist FinancialLower Price TargetHold$18.00 ➝ $17.00N/A
6/30/2022Jefferies Financial GroupLower Price TargetBuy$21.00 ➝ $20.00Low
6/3/2022Capital One FinancialInitiated CoverageEqual Weight ➝ Equal Weight$20.00Low
6/1/2022Morgan StanleyLower Price TargetEqual Weight$18.00 ➝ $17.50Low
5/19/2022Bank of AmericaDowngradeNeutral ➝ Underperform$18.00Low
4/26/2022BarclaysInitiated CoverageOverweight$20.00Low
3/9/2022Royal Bank of CanadaLower Price TargetSector Perform$19.00 ➝ $18.00Low
3/7/2022Morgan StanleyLower Price TargetEqual Weight$19.00 ➝ $18.00Medium
2/24/2022Colliers SecuritiesReiterated RatingBuy$20.00Medium
2/1/2022Credit Suisse GroupInitiated CoverageNeutral$19.00Medium
1/7/2022BMO Capital MarketsDowngradeOutperform ➝ Market Perform$20.00Low
11/29/2021Morgan StanleyLower Price TargetEqual Weight$20.00 ➝ $19.00Low
10/7/2021BMO Capital MarketsBoost Price TargetMarket Perform$32.50 ➝ $35.00Low
9/13/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$20.00Low
8/20/2021Raymond JamesDowngradeOutperform ➝ Market PerformMedium
7/16/2021Colliers SecuritiesReiterated RatingBuy$21.00Medium
6/14/2021Robert W. BairdDowngradeOutperform ➝ Neutral$19.00 ➝ $20.00Low
3/15/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight$20.00High
1/13/2021Jefferies Financial GroupUpgradeHold ➝ Buy$18.00 ➝ $20.00Medium
12/11/2020Morgan StanleyBoost Price TargetEqual Weight$14.00 ➝ $16.00High
11/11/2020B. RileyReiterated RatingBuyMedium
11/11/2020Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$20.00Low
9/9/2020Colliers SecuritiesInitiated CoverageBuy$22.00Low
8/31/2020Raymond JamesBoost Price TargetOutperform$19.00 ➝ $20.00Low
8/7/2020KeyCorpBoost Price TargetOverweight$18.00 ➝ $20.00Medium
7/2/2020CitigroupBoost Price TargetNeutral$14.00 ➝ $18.00Low
6/10/2020B. RileyBoost Price Target$19.00 ➝ $21.00Medium
5/8/2020B. RileyLower Price TargetBuy$22.00 ➝ $19.00Medium
4/29/2020Raymond JamesLower Price TargetOutperform$22.00 ➝ $19.00High
4/23/2020SunTrust BanksLower Price TargetHold$19.00 ➝ $16.00Medium
4/21/2020KeyCorpLower Price TargetOverweight$22.00 ➝ $18.00High
4/7/2020CitigroupDowngradeBuy ➝ Neutral$21.00 ➝ $14.00Medium
4/1/2020Berenberg BankUpgradeHold ➝ BuyHigh
3/30/2020MizuhoDowngradeHoldMedium
3/26/2020Morgan StanleyLower Price TargetEqual Weight$18.00 ➝ $14.00High
3/16/2020BTIG ResearchDowngradeBuy ➝ NeutralHigh
3/12/2020Raymond JamesBoost Price TargetOutperform$20.00 ➝ $22.00High
3/9/2020Royal Bank of CanadaReiterated RatingBuy$22.00High
3/9/2020BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$19.00 ➝ $23.00High
2/27/2020Capital One FinancialUpgradeEqual Weight ➝ Overweight$18.50 ➝ $22.00High
2/27/2020B. RileyBoost Price TargetBuy$20.00 ➝ $22.00High
1/16/2020KeyCorpBoost Price TargetOverweight$19.00 ➝ $20.00Medium
12/19/2019MizuhoInitiated CoverageBuy$20.00Low
12/12/2019CitigroupUpgradeNeutral ➝ Buy$18.50 ➝ $21.00High
11/26/2019Stifel NicolausUpgradeHold ➝ Buy$19.00 ➝ $21.00High
11/8/2019B. RileyReiterated RatingBuyLow
10/14/2019Bank of AmericaInitiated CoverageNeutralLow
9/17/2019Morgan StanleyLower Price TargetEqual Weight$19.00 ➝ $17.50Medium
9/12/2019Berenberg BankInitiated CoverageHold$18.00Low
6/20/2019CitigroupInitiated CoverageNeutral ➝ Neutral$18.50Medium
5/7/2019BMO Capital MarketsDowngradeOutperform ➝ Market Perform$17.45High
5/2/2019Capital One FinancialDowngradeOverweight ➝ Equal Weight$18.75Low
3/28/2019Morgan StanleySet Price TargetHold$19.00Medium
11/5/2018B. RileyReiterated RatingBuyLow
9/10/2018KeyCorpBoost Price TargetOverweight ➝ Buy$17.00 ➝ $18.00Medium
8/16/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$15.00 ➝ $16.00High
8/13/2018Jefferies Financial GroupReiterated RatingHold$18.00Low
8/7/2018Royal Bank of CanadaReiterated RatingBuy$18.00Low
8/7/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$17.00 ➝ $18.00Low
8/6/2018B. RileyBoost Price TargetBuy ➝ Buy$17.00 ➝ $18.00Low
8/3/2018Capital One FinancialUpgradeEqual Weight ➝ OverweightHigh
8/2/2018Cantor FitzgeraldReiterated RatingBuy$18.00High
5/24/2018Royal Bank of CanadaLower Price TargetOutperform ➝ Buy$18.00 ➝ $17.00Low
5/7/2018Cantor FitzgeraldReiterated RatingBuy$18.00Low
4/24/2018Stifel NicolausDowngradeBuy ➝ Hold$18.00 ➝ $17.00Medium
4/17/2018KeyCorpLower Price TargetOverweight ➝ Buy$20.00 ➝ $17.00Medium
4/16/2018BMO Capital MarketsReiterated RatingBuy$18.00Low
3/27/2018BMO Capital MarketsReiterated RatingBuy$18.00Low
3/20/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$18.00 ➝ $16.50Low
3/8/2018Bank of AmericaLower Price TargetBuy ➝ Buy$19.50 ➝ $18.00Low
3/6/2018Royal Bank of CanadaSet Price TargetBuy$18.00Low
3/2/2018Robert W. BairdSet Price TargetBuy$17.00Low
3/1/2018Stifel NicolausSet Price TargetBuy$18.00Low
3/1/2018B. RileySet Price TargetBuy ➝ Buy$20.00 ➝ $17.50Medium
2/28/2018SunTrust BanksSet Price TargetHold$16.00Low
2/28/2018Cantor FitzgeraldReiterated RatingBuy$18.00Medium
2/28/2018BMO Capital MarketsSet Price TargetBuy$19.00High
1/22/2018SunTrust BanksSet Price TargetHold$18.00Low
1/5/2018Robert W. BairdReiterated RatingOutperform ➝ Outperform$21.00 ➝ $19.00Low
12/7/2017Raymond JamesSet Price TargetBuy$20.00Low
11/15/2017Royal Bank of CanadaReiterated RatingBuy$21.00N/A
11/7/2017Cantor FitzgeraldBoost Price TargetOverweight$20.00 ➝ $21.00N/A
11/1/2017B. RileyReiterated RatingBuyN/A
10/12/2017KeyCorpUpgradeSector Weight ➝ OverweightN/A
10/4/2017Stifel NicolausReiterated RatingBuy$22.00Low
9/26/2017Cantor FitzgeraldReiterated RatingBuy$21.00Low
9/25/2017Capital One FinancialInitiated CoverageEqual Weight$19.50Low
9/22/2017Jefferies Financial GroupReiterated RatingHold$18.00 ➝ $19.00Medium
9/13/2017Cantor FitzgeraldReiterated RatingBuy$21.00Low
9/13/2017Royal Bank of CanadaReiterated RatingBuy$21.00Low
9/12/2017KeyCorpReiterated RatingHoldLow
8/21/2017Cantor FitzgeraldReiterated RatingOverweight$23.00 ➝ $21.00Low
8/21/2017Jefferies Financial GroupUpgradeUnderperform ➝ Hold$17.00 ➝ $18.00Low
(Data available from 8/10/2017 forward)

News Sentiment Rating

1.36 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/12/2022
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/11/2022
  • 5 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
3/13/2022
  • 5 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/12/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/12/2022
  • 5 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
6/11/2022
  • 9 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/11/2022
  • 10 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/10/2022

Current Sentiment

  • 10 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Physicians Realty Trust logo
Physicians Realty Trust is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. The Company invests in real estate that is integral to providing high quality healthcare. The Company conducts its business through an UPREIT structure in which its properties are owned by Physicians Realty L.P., a Delaware limited partnership (the operating partnership), directly or through limited partnerships, limited liability companies or other subsidiaries. The Company is the sole general partner of the operating partnership and, as of September 30, 2020, owned approximately 97.4% of OP Units.
Read More

Today's Range

Now: $17.93
Low: $17.84
High: $18.03

50 Day Range

MA: $17.28
Low: $16.47
High: $18.46

52 Week Range

Now: $17.93
Low: $16.07
High: $19.30

Volume

18,201 shs

Average Volume

2,360,201 shs

Market Capitalization

$4.04 billion

P/E Ratio

51.23

Dividend Yield

5.23%

Beta

0.79

Frequently Asked Questions

What sell-side analysts currently cover shares of Physicians Realty Trust?

The following Wall Street analysts have issued research reports on Physicians Realty Trust in the last year: Bank of America Co., Barclays PLC, BMO Capital Markets, Capital One Financial Co., Colliers Securities, Credit Suisse Group AG, Jefferies Financial Group Inc., Morgan Stanley, Raymond James, Royal Bank of Canada, StockNews.com, TheStreet, and Truist Financial Co..
View the latest analyst ratings for DOC.

What is the current price target for Physicians Realty Trust?

10 Wall Street analysts have set twelve-month price targets for Physicians Realty Trust in the last year. Their average twelve-month price target is $18.70, suggesting a possible upside of 4.3%. Barclays PLC has the highest price target set, predicting DOC will reach $20.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $16.00 for Physicians Realty Trust in the next year.
View the latest price targets for DOC.

What is the current consensus analyst rating for Physicians Realty Trust?

Physicians Realty Trust currently has 1 sell rating, 8 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in DOC, but not buy more shares or sell existing shares.
View the latest ratings for DOC.

What other companies compete with Physicians Realty Trust?

Other companies that are similar to Physicians Realty Trust include EPR Properties, Douglas Emmett, Apple Hospitality REIT, Broadstone Net Lease and Phillips Edison & Company, Inc.. Learn More about companies similar to Physicians Realty Trust.

How do I contact Physicians Realty Trust's investor relations team?

Physicians Realty Trust's physical mailing address is 309 N. WATER STREET SUITE 500, MILWAUKEE WI, 53202. The real estate investment trust's listed phone number is (414) 367-5600 and its investor relations email address is [email protected] The official website for Physicians Realty Trust is www.docreit.com. Learn More about contacing Physicians Realty Trust investor relations.